99 related articles for article (PubMed ID: 21349672)
1. Computer tomography, magnetic resonance imaging, and positron emission tomography or positron emission tomography/computer tomography for detection of metastatic lymph nodes in patients with ovarian cancer: a meta-analysis.
Yuan Y; Gu ZX; Tao XF; Liu SY
Eur J Radiol; 2012 May; 81(5):1002-6. PubMed ID: 21349672
[TBL] [Abstract][Full Text] [Related]
2. Diagnostic performance of computer tomography, magnetic resonance imaging, and positron emission tomography or positron emission tomography/computer tomography for detection of metastatic lymph nodes in patients with cervical cancer: meta-analysis.
Choi HJ; Ju W; Myung SK; Kim Y
Cancer Sci; 2010 Jun; 101(6):1471-9. PubMed ID: 20298252
[TBL] [Abstract][Full Text] [Related]
3. Prognostic value of volume-based metabolic parameters of
Han S; Kim H; Kim YJ; Suh CH; Woo S
Ann Nucl Med; 2018 Dec; 32(10):669-677. PubMed ID: 30101392
[TBL] [Abstract][Full Text] [Related]
4. An update on the role of PET/CT and PET/MRI in ovarian cancer.
Khiewvan B; Torigian DA; Emamzadehfard S; Paydary K; Salavati A; Houshmand S; Werner TJ; Alavi A
Eur J Nucl Med Mol Imaging; 2017 Jun; 44(6):1079-1091. PubMed ID: 28180966
[TBL] [Abstract][Full Text] [Related]
5. Cancer of the ovary, fallopian tube, and peritoneum: 2021 update.
Berek JS; Renz M; Kehoe S; Kumar L; Friedlander M
Int J Gynaecol Obstet; 2021 Oct; 155 Suppl 1(Suppl 1):61-85. PubMed ID: 34669199
[TBL] [Abstract][Full Text] [Related]
6. Lymph node metastasis in stages I and II ovarian cancer: a review.
Kleppe M; Wang T; Van Gorp T; Slangen BF; Kruse AJ; Kruitwagen RF
Gynecol Oncol; 2011 Dec; 123(3):610-4. PubMed ID: 21982047
[TBL] [Abstract][Full Text] [Related]
7. A meta-analysis of ¹⁸FDG-PET-CT, ¹⁸FDG-PET, MRI and bone scintigraphy for diagnosis of bone metastases in patients with lung cancer.
Qu X; Huang X; Yan W; Wu L; Dai K
Eur J Radiol; 2012 May; 81(5):1007-15. PubMed ID: 21354739
[TBL] [Abstract][Full Text] [Related]
8. The value of combined MRI, enhanced CT and
Hong Y; Peng J; Zeng Y; Deng X; Xu W; Wang J
Clin Transl Oncol; 2024 May; ():. PubMed ID: 38780807
[TBL] [Abstract][Full Text] [Related]
9. Role of Positron Emission Tomography/Computed Tomography in Epithelial Ovarian Cancer.
Chandra R; Kumari S; Bhatla N; Kumar R; Tiwari A; Sachani H; Kumar L
Indian J Nucl Med; 2023; 38(4):366-375. PubMed ID: 38390547
[TBL] [Abstract][Full Text] [Related]
10. Nomogram for predicting lymph node metastasis in patients with ovarian cancer using ultrasonography: a multicenter retrospective study.
Yang Y; Ye X; Zhou B; Liu Y; Feng M; Lv W; Lu D; Cui X; Liu J
BMC Cancer; 2023 Nov; 23(1):1121. PubMed ID: 37978453
[TBL] [Abstract][Full Text] [Related]
11. Feasibility of Sentinel Lymph Node Biopsy in Early-Stage Epithelial Ovarian Cancer: A Systematic Review and Meta-Analysis.
Zachou G; Yongue G; Chandrasekaran D
Diagnostics (Basel); 2023 Oct; 13(20):. PubMed ID: 37892029
[TBL] [Abstract][Full Text] [Related]
12. 18F-FDG PET/MRI and 18F-FDG PET/CT for the Management of Gynecological Malignancies: A Comprehensive Review of the Literature.
Allahqoli L; Hakimi S; Laganà AS; Momenimovahed Z; Mazidimoradi A; Rahmani A; Fallahi A; Salehiniya H; Ghiasvand MM; Alkatout I
J Imaging; 2023 Oct; 9(10):. PubMed ID: 37888330
[TBL] [Abstract][Full Text] [Related]
13. Diagnostic performance of noninvasive imaging using computed tomography, magnetic resonance imaging, and positron emission tomography for the detection of ovarian cancer: a meta-analysis.
Li X; Wang L; Guo P; Sun Q; Zhang Y; Chen C; Zhang Y
Ann Nucl Med; 2023 Oct; 37(10):541-550. PubMed ID: 37422857
[TBL] [Abstract][Full Text] [Related]
14. Predictive value of PET metabolic parameters for occult lymph node metastases in PET/CT defined node-negative patients with advanced epithelial ovarian cancer.
Xue B; Wang X
Sci Rep; 2023 Jun; 13(1):9439. PubMed ID: 37296189
[TBL] [Abstract][Full Text] [Related]
15. A Nomogram for Preoperative Prediction of the Risk of Lymph Node Metastasis in Patients with Epithelial Ovarian Cancer.
Xiang H; Yang F; Zheng X; Pan B; Ju M; Xu S; Zheng M
Curr Oncol; 2023 Mar; 30(3):3289-3300. PubMed ID: 36975463
[TBL] [Abstract][Full Text] [Related]
16. The Role of Positron Emission Tomography and Computed Tomographic (PET/CT) Imaging for Radiation Therapy Planning: A Literature Review.
Mallum A; Mkhize T; Akudugu JM; Ngwa W; Vorster M
Diagnostics (Basel); 2022 Dec; 13(1):. PubMed ID: 36611345
[TBL] [Abstract][Full Text] [Related]
17. Meta-analysis of the diagnostic value of
Wang X; Yang L; Wang Y
Front Oncol; 2022; 12():1003465. PubMed ID: 36419900
[TBL] [Abstract][Full Text] [Related]
18. Where are we going with sentinel nodes mapping in ovarian cancer?
Kampan NC; Teik CK; Shafiee MN
Front Oncol; 2022; 12():999749. PubMed ID: 36408149
[TBL] [Abstract][Full Text] [Related]
19. Prediction Model of Residual Neural Network for Pathological Confirmed Lymph Node Metastasis of Ovarian Cancer.
Yao H; Zhang X
Biomed Res Int; 2022; 2022():9646846. PubMed ID: 36267845
[TBL] [Abstract][Full Text] [Related]
20. Genome-Wide Identification and Validation of Gene Expression Biomarkers in the Diagnosis of Ovarian Serous Cystadenocarcinoma.
Zalfa F; Perrone MG; Ferorelli S; Laera L; Pierri CL; Tolomeo A; Dimiccoli V; Perrone G; De Grassi A; Scilimati A
Cancers (Basel); 2022 Aug; 14(15):. PubMed ID: 35954427
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
